Form 4: Repare Therapeutics Director Carol Schafer Acquires Stock Options
SEC Form 4 Filing
Director Carol Schafer of Repare Therapeutics Inc. acquired stock options exercisable for 27,200 common shares on June 17, 2024.
Summary
- Carol Schafer, a director of Repare Therapeutics Inc., filed a Form 4 to report changes in beneficial ownership.
- On June 17, 2024, Schafer acquired stock options for 27,200 common shares at an exercise price of $3.80.
- The options vest in equal monthly installments over twelve months from the grant date, contingent upon continued service.
- Following the transaction, Schafer directly owns options for 27,200 common shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock option grants, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of stock option grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of directors with those of shareholders.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of stock option grant |
| 06/16/2034 | Expiration date of the stock options |
| 06/20/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.